Piper Sandler adjusted its outlook on Keros Therapeutics (NASDAQ:KROS), significantly reducing the price target from $40.00 ...

Piper Sandler analyst Matt O’Brien says that last year was a painful one for shares of DexCom (DXCM), and while there are clearly still risks ...

Piper Sandler named UnitedHealth (NYSE:UNH) and CVS Health (NYSE:CVS) as its top picks in the managed care space, arguing ...

The 'Loose Women' panelist wrote on Instagram that she's trying “a prosthetic eye shell” after years of “battling” eye health ...

Columnists Tiyya Geiger and Piper Slinka-Petka discuss how the media’s reaction to murder charges against 2020 Engineering ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

Maria Cornilsen joined DLA Piper as a partner in its leveraged finance practice in New York, the firm announced Jan. 15.

Katie Piper has decided to get an "artificial eye" more than 16 years after an acid attack which left her with serious ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target ...